Dosing with Enbrel® can be individualised based on the needs of each patient1
Patients treated with Enbrel should be given the Patient Card.
The recommended dose of Enbrel for adult patients with RA, PsA and axSpA (AS or nr-AxSpA) is:1
In patients with PsA and axSpA (AS or nr-AxSpA), available data suggest that a clinical response is usually achieved within 12 weeks of treatment. Continued therapy should be carefully reconsidered in patients not responding within this time period1
Learn more about the efficacy and safety of Enbrel in RA
Pfizer has resources available to support you and your Enbrel patients
Legal Category: S1A
Further information is available upon request
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023